What medicine should not be taken with atorvastatin?
What medicine should not be taken with atorvastatin?
Severe interactions of atorvastatin include:
- cyclosporine.
- gemfibrozil.
- pazopanib.
- red yeast rice.
- telaprevir.
- tipranavir.
Can you take atorvastatin and Norco together?
No interactions were found between atorvastatin and Norco.
Is atorvastatin 10 mg safe?
Conclusions: In hypercholesterolemia patients, atorvastatin 10 mg every other day is safe and effective in lowering TC, TG, with LDL-c and a slight increase in HDL-c.
Can I drink orange juice while taking atorvastatin?
Orange juice is safe to drink with Atorvastatin. Contact your prescriber immediately if you experience unexplained muscle aches, muscle pain or tenderness, general weakness or fatigue, side or back pain, or decreased urination while taking Atorvastatin.
What are the strengths of atorvastatin oral tablets?
Form: oral tablet; Strengths: 10 mg, 20 mg, 40 mg, and 80 mg; Brand: Lipitor. Form: oral tablet; Strengths: 10 mg, 20 mg, 40 mg, and 80 mg; Dosage for prevention of heart
Are there any side effects of taking Lortab with alcohol?
Daily alcohol use, especially when combined with acetaminophen, may damage your liver. Avoid alcohol. Before using this medication, women of childbearing age should talk with their doctor (s) about the risks and benefits.
What kind of pain does Lortab 2.5 / 500 cause?
Lortab 2.5/500 (Hydrocodone Bitartrate and Acetaminophen Tablets, USP) are indicated for the relief of moderate to moderately severe pain. Lortab 2.5/500 (Hydrocodone Bitartrate and Acetaminophen Tablets, USP) are indicated for the relief of moderate to moderately severe pain.
How is atorvachol used to treat high cholesterol?
In some patients, Atorvachol is used to treat high cholesterol and high triglycerides together. In most people, there are no symptoms of abnormal cholesterol or triglyceride levels. Your doctor can measure your levels with a simple blood test. Atorvachol belongs to a group of medicines called HMG-CoA reductase inhibitors.
